Forbion raises €2.3 billion with Lilly backing, launches largest Dutch VC fund to back ~30 life-science firms
Forbion, a Netherlands-based life-science investor, announced it has closed two new funds totaling €2.3 billion ($2.6 billion), the largest capital raise in Dutch venture-capital history.
The fundraising was supported by Eli Lilly, which committed a portion of the capital, giving Forbion additional credibility among biotech investors.
With the new pool of money, Forbion plans to invest in roughly 30 portfolio companies across its therapeutic focus areas, aiming to accelerate development and commercialization.
The influx of capital reflects strong investor appetite for European biotech and positions Forbion to play a larger role in funding innovative drug discovery projects.
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Forbion gets Lilly's backing in Dutch VC's largest-ever fundraising haul”
read at Endpoints ↗
comments(0)
5-min edit window · permanent after that